tocophersolan has been researched along with Glaucoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, L; Jiang, C; Jin, Q; Jin, Z; Li, H; Liu, Y; Oswald, J; Song, X; Wang, F; Wu, J; Zhou, Y | 1 |
Ahmad, FJ; Anwar, M; Garg, V; Jain, GK; Khar, RK; Talegaonkar, S; Warsi, MH | 1 |
2 other study(ies) available for tocophersolan and Glaucoma
Article | Year |
---|---|
TPGS modified nanoliposomes as an effective ocular delivery system to treat glaucoma.
Topics: Animals; Carbonic Anhydrase Inhibitors; Cell Line; Chemistry, Pharmaceutical; Cornea; Delayed-Action Preparations; Drug Delivery Systems; Glaucoma; Intraocular Pressure; Liposomes; Male; Mice; Nanoparticles; Particle Size; Permeability; Rabbits; Sulfonamides; Thiazines; Vitamin E | 2018 |
Dorzolamide-loaded PLGA/vitamin E TPGS nanoparticles for glaucoma therapy: Pharmacoscintigraphy study and evaluation of extended ocular hypotensive effect in rabbits.
Topics: Animals; Carbonic Anhydrase Inhibitors; Glaucoma; Intraocular Pressure; Lactic Acid; Microscopy, Electron, Scanning; Nanoparticles; Ocular Hypertension; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Radionuclide Imaging; Sulfonamides; Thiophenes; Vitamin A; Vitamin E | 2014 |